Malignant Uveal Neoplasm — Trials

Malignant Uveal Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

232 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 59
Recruiting: 29
Ph III recruiting: 6
Growth YoY: —
Industry share: 36%
Top sponsor: IDEAYA Biosciences
Termination share: 33.3%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (34)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03022565	Vorinostat in Patients With Class 2 High Risk Uveal Melanoma	withdrawn	Early Phase 1	0	University of MiamiOTHER	0	Feb 6, 2020	clinicaltrials
NCT01730157	Radioembolization and Ipilimumab in Treating Patients With Uveal Melanoma With Liver Metastases	terminated	Early Phase 1	6	Case Comprehensive Cancer CenterOTHER	1	Mar 10, 2016	clinicaltrials